211 related articles for article (PubMed ID: 32253501)
41. [Neuropsychiatric manifestations in systemic lupus erythematosus].
Alexa ID; Stoica MS; Paraschiv O; Rusu RI
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):322-5. PubMed ID: 17802940
[TBL] [Abstract][Full Text] [Related]
42. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
[TBL] [Abstract][Full Text] [Related]
43. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
[TBL] [Abstract][Full Text] [Related]
44. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
[TBL] [Abstract][Full Text] [Related]
45. Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.
Fanouriakis A; Pamfil C; Sidiropoulos P; Damian L; Flestea A; Gusetu G; Rednic S; Bertsias G; Boumpas DT
Lupus; 2016 May; 25(6):627-36. PubMed ID: 26692040
[TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
Podrazilová L; Peterová V; Olejárová M; Tegzová D; Krásenský J; Seidl Z; Kozelek P; Dostál C
Clin Exp Rheumatol; 2008; 26(4):604-10. PubMed ID: 18799091
[TBL] [Abstract][Full Text] [Related]
47. MR Diffusion Tractography to Identify and Characterize Microstructural White Matter Tract Changes in Systemic Lupus Erythematosus Patients.
Shastri R; Shah G; Wang P; Cagnoli P; Schmidt-Wilcke T; McCune J; Harris R; Sundgren P
Acad Radiol; 2016 Nov; 23(11):1431-1440. PubMed ID: 27746120
[TBL] [Abstract][Full Text] [Related]
48. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
[TBL] [Abstract][Full Text] [Related]
49. Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S; Schorb E; Zucca E; Hemkens LG; Schandelmaier S; Kasenda B
Hematol Oncol; 2019 Dec; 37(5):548-557. PubMed ID: 31418878
[TBL] [Abstract][Full Text] [Related]
50. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
[TBL] [Abstract][Full Text] [Related]
51. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
52. Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
Zabala A; Salgueiro M; Sáez-Atxukarro O; Ballesteros J; Ruiz-Irastorza G; Segarra R
J Int Neuropsychol Soc; 2018 Jul; 24(6):629-639. PubMed ID: 29553037
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide.
Kato R; Sumitomo S; Kawahata K; Fujio K; Yamamoto K
Lupus; 2015 Jul; 24(8):880-4. PubMed ID: 25661835
[TBL] [Abstract][Full Text] [Related]
54. Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.
Chamberlain MC
J Neurooncol; 2013 May; 113(1):27-32. PubMed ID: 23456654
[TBL] [Abstract][Full Text] [Related]
55. Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus.
Papadaki E; Fanouriakis A; Kavroulakis E; Karageorgou D; Sidiropoulos P; Bertsias G; Simos P; Boumpas DT
Ann Rheum Dis; 2018 Mar; 77(3):441-448. PubMed ID: 29259047
[TBL] [Abstract][Full Text] [Related]
56. Numerous Fusiform and Saccular Cerebral Aneurysms in Central Nervous System Lupus Presenting with Ischemic Stroke.
Majidi S; Leon Guerrero CR; Gandhy S; Burger KM; Sigounas D
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e126-e128. PubMed ID: 28479183
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.
Iwata S; Saito K; Hirata S; Ohkubo N; Nakayamada S; Nakano K; Hanami K; Kubo S; Miyagawa I; Yoshikawa M; Miyazaki Y; Yoshinari H; Tanaka Y
Lupus; 2018 Apr; 27(5):802-811. PubMed ID: 29308726
[TBL] [Abstract][Full Text] [Related]
58. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
59. A Case of Cutaneous B-Cell Lymphoma in Longstanding Systemic Lupus Erythematosus.
Zarins A; Smith D; Fahim S
J Cutan Med Surg; 2016 Nov; 20(6):579-581. PubMed ID: 27358312
[TBL] [Abstract][Full Text] [Related]
60. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
